Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 651

1.

Evaluation of osmolality and pH of various concentrations of methotrexate, cytarabine, and thiotepa prepared in normal saline, sterile water for injection, and lactated Ringer's solution for intrathecal administration.

de Lemos ML, Monfared S, Denyssevych T, Hamata L, Jennings S, Thiessen B, Smith S, Waterhouse D.

J Oncol Pharm Pract. 2009 Mar;15(1):45-52. doi: 10.1177/1078155208096902. Epub 2008 Sep 4. Review.

PMID:
18772215
2.
3.

Stability of cytarabine, methotrexate sodium, and hydrocortisone sodium succinate admixtures.

Cheung YW, Vishnuvajjala BR, Flora KP.

Am J Hosp Pharm. 1984 Sep;41(9):1802-6.

PMID:
6496516
4.

CroFab reconstitution in various media: an in vitro solubility study.

Vohra R, Clark R, Kelner M.

Clin Toxicol (Phila). 2008 Nov;46(9):808-10. doi: 10.1080/15563650802089515.

PMID:
18821147
5.

Fetal electrolyte and acid-base responses to amnioinfusion: lactated Ringer's versus normal saline in the ovine fetus.

Shields LE, Moore TR, Brace RA.

J Soc Gynecol Investig. 1995 Jul-Aug;2(4):602-8.

PMID:
9420864
6.
8.
9.

Stability of four standardized preparations of methotrexate, cytarabine, and hydrocortisone for intrathecal use.

Olmos-Jiménez R, Espuny-Miró A, Díaz-Carrasco MS, Fernández-Varón E, Valderrey-Pulido M, Cárceles-Rodríguez C.

J Oncol Pharm Pract. 2016 Oct;22(5):659-65. doi: 10.1177/1078155215600905. Epub 2015 Aug 12.

PMID:
26271105
10.

The effects of amnioinfused solutions for meconium-stained amniotic fluid on neonatal plasma electrolyte concentrations and pH.

Gonzalez JL, Mooney S, Gardner MO, Martin D, Curet LB.

J Perinatol. 2002 Jun;22(4):279-81.

11.

Osmolality of small-volume intravenous admixtures.

Wermeling DP, Rapp RP, DeLuca PP, Piecoro JJ Jr.

Am J Hosp Pharm. 1985 Aug;42(8):1739-44.

PMID:
4036971
12.

Various irrigation fluids affect postoperative brain edema and cellular damage during experimental neurosurgery in rats.

Doi K, Kawano T, Morioka Y, Fujita Y, Nishimura M.

Surg Neurol. 2006 Dec;66(6):565-71; discussion 571-2.

PMID:
17145310
13.

Physical compatibility of telavancin hydrochloride with select i.v. drugs during simulated Y-site administration.

Housman ST, Tessier PR, Nicolau DP, Kuti JL.

Am J Health Syst Pharm. 2011 Dec 1;68(23):2265-70. doi: 10.2146/ajhp100663.

PMID:
22095816
14.

Stability of nicardipine hydrochloride in intravenous solutions.

Baaske DM, DeMay JF, Latona CA, Mirmira S, Sigvardson KW.

Am J Health Syst Pharm. 1996 Jul 15;53(14):1701-5.

PMID:
8827237
15.
16.

Hemolysis of erythrocytes by primary pharmacologic agents, part 2: influence of the vehicle.

Ansel HC, Gigandet MP.

Am J Hosp Pharm. 1976 Dec;33(12):1264-7.

PMID:
11686
17.

[Pharmacokinetics of intrathecal chemotherapy and clinical problems].

Fujimoto T.

Gan To Kagaku Ryoho. 1984 Aug;11(8):1536-42. Japanese.

PMID:
6433796
18.

Concentration-time profile of phenytoin after admixture with small volumes of intravenous fluids.

Cloyd JC, Bosch DE, Sawchuk RJ.

Am J Hosp Pharm. 1978 Jan;35(1):45-8.

PMID:
623117
19.

Intrathecal chemotherapy in carcinomatous meningitis from breast cancer.

Orlando L, Curigliano G, Colleoni M, Fazio N, Nole F, Martinelli G, Cinieri S, Graffeo R, Peruzzotti G, Goldhirsch A.

Anticancer Res. 2002 Sep-Oct;22(5):3057-9.

PMID:
12530042
20.

The effect of intravenous lactated Ringer's solution versus 0.9% sodium chloride solution on serum osmolality in human volunteers.

Williams EL, Hildebrand KL, McCormick SA, Bedel MJ.

Anesth Analg. 1999 May;88(5):999-1003.

PMID:
10320158

Supplemental Content

Support Center